TORONTO, Ontario and CAMBRIDGE, Massachusetts, March 13, 2023 (GLOBE NEWSWIRE) ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN), a biotechnology company…
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022 - read this article along with other careers information, tips and advice on BioSpace